Inactive Instrument

Nimutan AB (publ) Stock

NIMU

SE0001789793

Latest news: Nimutan AB (publ)

24-05-06	Nimutan AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI
22-11-02	Nimutan AB agreed to Spin-Off 1.6% stake in Humble Group AB (OM:HUMBLE).	CI
22-07-29	Nimutan AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
22-04-29	Nimutan AB Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
21-11-03	MedicaNatumin AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-08-24	Medicanatumin AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI
21-04-13	MedicaNatumin AB Reports Earnings Results for the Full Year Ended December 31, 2020	CI
19-12-15	MedicaNatumin AB acquired Vitalkost AS for NOK 26 million.	CI
17-08-24	Medica Clinical Nord Holding AB Reports Consolidated Earnings Results for the Six Months Ended June 30, 2017	CI
16-05-25	TJ Gruppen AB and JOOL Invest AB cancelled the acquisition of 11.77% stake in Medica Clinical Nord Holding AB from QV Private Equity AB.	CI
16-03-16	Medica Clinical Nord Holding AB (NGM:MCNH MTF) acquired Natumin Pharma AB for SEK 31.5 million.	CI
15-05-25	TJ Gruppen AB and JOOL Invest AB agreed to acquire 11.77% stake in Medica Clinical Nord Holding AB from QV Private Equity AB.	CI
15-05-12	The founders acquired an additional 3.36% stake in Medica Clinical Nord Holding AB from QV Private Equity AB.	CI

More news

Managers and Directors: Nimutan AB (publ)

Manager	Title	Age	Since
Peter Hencz CEO	Chief Executive Officer	-	2020-12-31
Emil Svahn DFI	Director of Finance/CFO	40	-
Andreas Andersson CTO	Chief Tech/Sci/R&D Officer	-	-

Director	Title	Age	Since
Anna Maria Christina Stålenbring BRD	Director/Board Member	65	2019-12-31
Bengt Johansson BRD	Director/Board Member	-	2017-04-30
Lars Kärnerud BRD	Director/Board Member	76	2016-04-30

More insiders

Special Foods & Wellbeing Products

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NIMUTAN AB (PUBL)	+8.11%	-24.53%	-	-	1.44M
NESTLÉ S.A.	-1.58%	+1.36%	+8.51%	-13.82%	269B
MONDELEZ INTERNATIONAL, INC.	-1.20%	+1.66%	+15.46%	-3.61%	83.57B
DANONE	-2.10%	+2.44%	-14.17%	+18.07%	48.14B
GRUPO NUTRESA S. A.	-0.78%	-0.68%	+25.98%	+557.35%	44.99B
THE HERSHEY COMPANY	+0.37%	+7.53%	+4.38%	-5.02%	35.79B
ARCHER-DANIELS-MIDLAND COMPANY	-0.71%	-9.02%	+22.80%	-2.97%	33.3B
FOSHAN HAITIAN FLAVOURING AND FOOD COMPANY LTD.	+0.36%	+2.64%	-5.77%	-6.09%	30.69B
INNER MONGOLIA YILI INDUSTRIAL GROUP CO., LTD.	+1.29%	+4.31%	+15.24%	+13.95%	29.79B
KRAFT HEINZ	-2.80%	+1.11%	+1.36%	-25.63%	29.13B
Average	+0.10%	+1.33%	+8.20%	+59.14%	67.2B
Weighted average by Cap.	-1.17%	+1.39%	+8.77%	+34.92%

See all sector performances

Nimutan AB (publ), formerly MedicaNatumin AB is a Sweden-based healthcare products company that develops and manufactures dietary supplements, medical devices and dermatological and cosmetic products. The Company's series consist of documented products in men's and women's health, general health and skin care. The products fall into the categories of dietary supplements, medical technology and dermatological and cosmetic products. The brands include dietary supplements such as L-Argiplex and Nypozin and the scientifically documented skin care series Jabushe. The Company also has the distribution rights for dietary supplements such as Astaxin, Ester-C and Kyolic. Nimutan AB is certified according to Svensk Egenvard's system for safe dietary supplements for consumers.

Employees

Sector

Food Processing

More about the company